Bela Denes
Bela Denes has become chief medical officer for Clarus Therapeutics.
He joins the firm from Abbott Laboratories where he was head of therapeutic drug discovery and development efforts in the men’s health division.
Leveraging his 35 year career in urology research, Denes will now focus on developing oral formulations for testosterone replacement therapies, which he says have “enormous market potential.”
Robert Dudley added: "Bela's extensive clinical and industry experience in urology and men's health will be invaluable as CLR-610, our oral testosterone replacement candidate, nears the end of Phase III clinical development.”